Epigallocatechin Gallate Protects Diabetes Mellitus Rats Complicated with Cardiomyopathy through TGF- β1/JNK Signaling Pathway

CONCLUSION: The results demonstrated that EGCG could improve STZ-induced diabetic complication, i.e., myocardial fibrosis, in diabetic rats, and protect their heart through TGF-β1/JNK signaling pathway.PMID:36173051 | DOI:10.2174/1381612828666220902115437

Source: Current Pharmaceutical Design - September 29, 2022 Category: Drugs & Pharmacology Authors: Liuming Gui Fengxian Wang Xiangka Hu Xiaojuan Liu He Yang Zeng Xiao Rui Cai Mu Shuang Qi Chunmei Dai Source Type: research